FDA approves expanded dose range for Latuda (Sunovion Pharma) in treatment of adult Schizophrenia - 07-May-2012
The FDA has approved an expanded dose range for Latuda (lurasidone), from Sunovion Pharma, for treatment of adults with Schizophrenia. The new recommended dose range (40-160 mg/day) includes approval of 120 mg/day and 160 mg/day doses plus a new 120 mg tablet. This expanded range is based on results from five studies evaluating the safety and efficacy of Latuda, in which doses of between 40 mg/day and 160 mg/day were shown to be safe and effective.
Related News
Teva Pharmaceutical Industries will market Adasuve for treatment of agitation in Schizophrenia in the United States
Vanda Pharmaceuticals withdraws EU MMA for Fanaptum to treat Schizophrenia
FDA approves Abilify Maintena as a treatment for Schizophrenia
Adasuve ( Alexza/Ferrer) is EU approved to control agitation in Schizophrenia patients
Abilify Depot is filed in EU for maintenance therapy of Schizophrenia
CHMP rejects Fanaptum (Vanda Pharma)for treatment of Schizophrenia
CHMP recommends Adusive (Alexza/Ferrer)for control of agitation in Schizophrenia and Bipolar patients
Forest files cariprazine at FDA for Schizophrenia and Bipolar Disorder
Related Psychiatry/Mental Health Information
Psychiatry/Mental Health Clinical Guidelines
Generalised anxiety disorder and panic disorder (with or without agoraphobia) in adults
NICEBipolar disorder : The management of bipolar disorder in adults, children and adolescents, in primary and secondary care
NICEPsychiatry/Mental Health Clinical Trials
Cognitive Remediation in ADHD Children : Comparison Between Three Therapeutic Strategies : Cognitive Remediation With a Virtual Classroom Software and Methylphenidate and Supportive Psychotherapy (RECOGNITA)
Clinicaltrials.gov 26 March 2013Essential Fatty Acids in Adult ADHD (OCEAN-GER)
Clinicaltrials.gov 19 February 2013Psychiatry/Mental Health Medical Journal Abstracts
Optimizing arousal to manage aggression: A pilot study of sensory modulation
International Journal of Mental Health Nursing 03 February 2013Manifestations of interpersonal dependency and depressive subtypes in outpatient psychotherapy patients
Personality and Mental Health 29 January 2013Psychiatry/Mental Health Medical Apps
Schizophrenia Psychopharmacology
£10.49
Mental Health Forum
Free
Advert for Healthcare Professionals only